Clinical Trials
3 trialsNCT04055792 2023-06-28
Sintilimab Combined With Anlotinib as Second or Further-line Therapy for ED-SCLC
Henan Cancer Hospital
Phase 2 Completed
NCT01878448 2019-05-22
ALTN/STS
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2 Completed
NCT01874873 2019-05-21
ALTN/MTC
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2 Completed